A study that used a specific kallikrein assay did not find evidence for the presence of intratumoral kallikrein in the primary tumors of 6 CS patients, and routinely measured plasma kallikrein concentrations in 20 CS patients did not statistically differ from those measured in 17 controls (48). Here, KLK4 is linked to Cowden syndrome 1.